Advertisement

Topics

MeiraGTx Company Profile

19:09 EDT 24th April 2018 | BioPortfolio

MeiraGTx is committed to the development of novel gene therapies to transform the lives of patients suffering from acquired and inherited disorders. The company is developing potential treatments for ocular diseases, including rare inherited blindness and age-related macular degeneration (AMD). MeiraGTx is also developing potential treatments for xerostomia, a frequent and debilitating side effect of radiation treatment used in head and neck cancers, as well as certain neurodegenerative diseases. In addition, MeiraGTx is developing novel gene regulation platforms that it believes will transform the way gene therapy can be applied and create new paradigms for biologic therapeutics.


News Articles [12 Associated News Articles listed on BioPortfolio]

Oxford Genetics Forms Adeno-associated Virus Collaboration with MeiraGTx

MeiraGTx gets research and manufacturing rights to novel serotype specific AAV vectors

MeiraGTx obtains rare disease designation for gene therapy A001

Gene therapies developer MeiraGTx has obtained rare paediatric disease designation from the US Food and Drug Administration (FDA) for its...Read More... The post MeiraGTx obtains rare disease designat...

Oxford Genetics announces adeno-associated virus collaboration with MeiraGTx

Oxford Genetics, a leader in innovative synthetic biology-based technologies for biologics discovery, development and delivery, has established a new agreement with clinical-stage gene therapy company...

Oxford Genetics and MeiraGTx collaborate on AAV vectors

UK-based synthetic biology company, Oxford Genetics, has established a new agreement with clinical-stage gene therapy company, MeiraGTx, for the development of novel adeno-associated virus (AAV) vecto...

Oxford and MeiraGTx to make AAVs in Central London, UK

Oxford Genetics has teamed with MeiraGTx to develop GMP-grade AAVs at a manufacturing facility in Central London, UK.

MeiraGTx's AAV-RPGR for retinitis pigmentosa gets fast track designation

The FDA has granted fast track designation to AAV-RPGR for the treatment of X-linked retinitis pigmentosa, MeiraGTx announced in a press release.The fast track process will allow MeiraGTx to have earl...

MeiraGTx’s Leber’s Congenital Amaurosis Drug Receives Rare Pediatric Disease Designation from the FDA

LONDON and NEW YORK, Dec. 7, 2017 /PRNewswire/ — MeiraGTx, a London and New York-based gene therapy company, today announced that the Offices of Orphan Products Development and Pediatric Therape...

FDA Grants Fast Track Status to MeiraGTx’s AAV-RPGR for the Treatment of X-Linked Retinitis Pigmentosa Due to RPGR Deficiency

LONDON & NEW YORK–(BUSINESS WIRE)–MeiraGTx Limited, a vertically integrated, clinical stage gene therapy company, today announced that the U.S. Food and Drug Administration (FDA) has g...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

MeiraGTx

MeiraGTx is committed to the development of novel gene therapies to transform the lives of patients suffering from acquired and inherited disorders. The company is developing pote...

MeiraGTx Limited

MeiraGTx is committed to the development of novel gene therapies to transform the lives of patients suffering from acquired and inherited disorders. The company is developing pote...

More Information about "MeiraGTx" on BioPortfolio

We have published hundreds of MeiraGTx news stories on BioPortfolio along with dozens of MeiraGTx Clinical Trials and PubMed Articles about MeiraGTx for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of MeiraGTx Companies in our database. You can also find out about relevant MeiraGTx Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...

Ophthalmology
Ophthalmology is the branch of medicine that is devoted to the study and treatment of eye diseases. As well as mild visual defects correctable by lenses, ophthalmology is concerned with glaucoma, uveitis and other serious conditions affecting the eye, ...


Corporate Database Quicklinks



Searches Linking to this Company Record